SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-21-017317
Filing Date
2021-05-14
Accepted
2021-05-14 06:01:54
Documents
12
Period of Report
2021-05-12
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K nt10022735x18_8k.htm   iXBRL 8-K 42868
  Complete submission text file 0001140361-21-017317.txt   179396

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA advm-20210512.xsd EX-101.SCH 3920
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE advm-20210512_lab.xml EX-101.LAB 22544
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE advm-20210512_pre.xml EX-101.PRE 16040
5 EXTRACTED XBRL INSTANCE DOCUMENT nt10022735x18_8k_htm.xml XML 4044
Mailing Address 800 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 800 SAGINAW DRIVE REDWOOD CITY CA 94063 650-272-6269
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36579 | Film No.: 21921781
SIC: 2836 Biological Products, (No Diagnostic Substances)